Skip to content

African studies identify strategies for improving treatment adherence, retention in care

Good adherence to HIV treatment, undetectable viral load, reduce the risk of anal infection with high-risk HPV types for MSM with HIV

HIV rebound linked to higher baseline level, slower suppression and low-level viraemia

Laura Waters of Mortimer Market Centre speaking at EACS 2013. Photo by Liz Highleyman, hivandhepatitis.com

Eviplera works well regardless of viral load or CD4 count, may improve lipid levels

Pablo Tebas, University of Pennsyvania, reports results of the SPIRIT study at ID Week 2013. Photo by Liz Highleyman, hivandhepatitis.com

Long-acting antiretrovirals may improve survival for people with poor adherence

Eric Ross, from Massachusetts General Hospital in Boston, speaking at the ID Week Conference.

Single-tablet regimen improves antiretroviral adherence and reduces hospitalisation

Scott Sutton, from the Dorn Veterans Administration Medical Center and the University of South Carolina, speaking at ICAAC 2013.

Systematic review confirms that regular viral load monitoring assists adherence to HIV therapy

Persisently detectable viral load at any level increases risk of HIV treatment failure

ARV and TB medicine drug supply issues threaten South Africa’s ARV programme